Redefining Precision Therapeutics in Hematologic Malignancies: Current Practice and Next Questions on Bispecific Antibodies

Share

Program Content

Activities

  • bsAbs in Hem Malignancies
    Redefining Precision Therapeutics in Hematologic Malignancies: Bispecific Antibodies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 17, 2024

    Expires: May 17, 2025

  • 2024 APPlexus Bispecific Antibodies Heme
    Redefining Precision Therapeutics in Hematologic Malignancies: Current Practice and Next Questions on Bispecific Antibodies
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2024

    Expires: December 30, 2024

Faculty

cover img faculity

Sherry Adkins, MSN, ANP-C, FAAN

Advanced Practice Provider Supervisor
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center 9500 Euclid Avenue CA-6
Cleveland, Ohio

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC